Affimed NV

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.66%58.760.0%$901.22m
AMGNAmgen, Inc. 0.76%258.191.3%$755.21m
NVAXNovavax, Inc. 30.83%103.93102.0%$724.94m
GILDGilead Sciences, Inc. 0.08%76.821.0%$694.93m
REGNRegeneron Pharmaceuticals, Inc. 3.84%651.322.5%$687.69m
BIIBBiogen, Inc. 0.43%270.951.6%$580.52m
VRTXVertex Pharmaceuticals, Inc. 4.80%305.281.9%$535.94m
ILMNIllumina, Inc. -0.28%378.333.5%$303.86m
ALXNAlexion Pharmaceuticals, Inc. -0.47%113.042.0%$234.38m
BMRNBioMarin Pharmaceutical, Inc. 1.67%129.844.3%$221.08m
SGENSeattle Genetics, Inc. 4.15%177.526.1%$206.98m
SRNESorrento Therapeutics, Inc. 2.86%7.371.8%$197.37m
IMMUImmunomedics, Inc. 1.99%41.4411.0%$182.27m
SRPTSarepta Therapeutics, Inc. 3.13%168.6113.9%$176.51m
INCYIncyte Corp. 1.79%109.722.5%$167.27m

Company Profile

Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.